Nalbuphine

From WikiMD's Medical Encyclopedia

Revision as of 10:49, 23 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

An opioid analgesic used in pain management


Nalbuphine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Nalbuphine is a synthetic opioid used primarily in the management of moderate to severe pain. It is known for its mixed agonist-antagonist properties, which make it unique among opioid analgesics.

Pharmacology

Nalbuphine acts as an agonist at the kappa-opioid receptor and as a partial antagonist at the mu-opioid receptor. This dual action results in effective analgesia with a lower risk of respiratory depression compared to pure mu-opioid agonists like morphine.

Mechanism of Action

Nalbuphine binds to opioid receptors in the central nervous system, altering the perception of and response to pain. Its kappa agonist activity is responsible for its analgesic effects, while its mu antagonist activity helps mitigate some of the adverse effects commonly associated with opioids, such as respiratory depression and euphoria.

Clinical Use

Nalbuphine is used in various clinical settings, including postoperative pain management, labor pain, and as an adjunct to anesthesia. It is administered via intravenous, intramuscular, or subcutaneous injection.

Advantages

One of the main advantages of nalbuphine is its ceiling effect on respiratory depression, which makes it safer in terms of overdose risk compared to other opioids. This property is particularly beneficial in settings where monitoring of respiratory function is limited.

Side Effects

Common side effects of nalbuphine include sedation, dizziness, nausea, and sweating. Due to its partial antagonist properties, it may precipitate withdrawal symptoms in patients who are physically dependent on other opioids.

Regulation and Availability

Nalbuphine is not classified as a controlled substance in many countries, which facilitates its use in various medical settings. However, its availability may vary depending on local regulations and healthcare policies.

Related pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.